高级检索
    张力, 张国淳. 贝伐单抗与埃罗替尼联合治疗复发性非小细胞肺癌患者的Ⅰ/Ⅱ期临床试验[J]. 循证医学, 2006, 6(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2006.04.007
    引用本文: 张力, 张国淳. 贝伐单抗与埃罗替尼联合治疗复发性非小细胞肺癌患者的Ⅰ/Ⅱ期临床试验[J]. 循证医学, 2006, 6(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2006.04.007
    shu
    ZHANG Li, ZHANG Guo-chun. Phase Ⅰ/Ⅱ Trial Evaluating Bevacizumab in Combination with Erlotinib for Patients with Recurrent Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2006.04.007
    Citation: ZHANG Li, ZHANG Guo-chun. Phase Ⅰ/Ⅱ Trial Evaluating Bevacizumab in Combination with Erlotinib for Patients with Recurrent Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2006.04.007
    shu

    贝伐单抗与埃罗替尼联合治疗复发性非小细胞肺癌患者的Ⅰ/Ⅱ期临床试验

    Phase Ⅰ/Ⅱ Trial Evaluating Bevacizumab in Combination with Erlotinib for Patients with Recurrent Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回